Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer (SA02)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Institut Paoli-Calmettes.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Institut Paoli-Calmettes Identifier:
First received: May 29, 2009
Last updated: March 19, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)